Research and Education is pleased to have the Lymphoma Information Network in the family of

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough

Gilead Sciences has announced results of the company's Phase II study of its

In a large trial of older, newly diagnosed patients with

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase

This past weekend, St. Baldrick's Foundation brought its hair clippers to Dell Children'

Not all retail-driven fundraising ideas are created equally. And none of them do it the

"When she gets pricked by a needle before donating blood, dietetics junior Sarah Mroczek said

A prospective randomized trial carried out by French researchers examined whether maintenance

The Leukemia and Lymphoma Society hones in on four critical areas to be researched:


Talon Therapeutics has submitted a new drug application (NDA) to the US FDA seeking accelerated

The FDA's Oncologic Drugs Advisory Committee today voted 7-1 to recommend to the agency that

The incredible breakthrough blockbuster leukemia drug Gleevec has saved tens of thousands of